BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Feng QY, Wei Y, Chen JW, Chang WJ, Ye LC, Zhu DX, Xu JM. Anti-EGFR and anti-VEGF agents: Important targeted therapies of colorectal liver metastases. World J Gastroenterol 2014; 20(15): 4263-4275 [PMID: 24764664 DOI: 10.3748/wjg.v20.i15.4263]
URL: https://www.wjgnet.com/1007-9327/full/v20/i15/4263.htm
Number Citing Articles
1
Pasquale F. Innominato, René Adam. Use of Bevacizumab in the Management of Potentially Resectable Colorectal Liver Metastases: Safety, Pathologic Assessment and BenefitCurrent Colorectal Cancer Reports 2016; 12(4): 208 doi: 10.1007/s11888-016-0326-5
2
Francisco Navarro Freire, Patricia Navarro Sánchez, Benito Mirón Pozo, María Teresa Delgado Ureña, José Antonio Jiménez Ríos, Pedro Antonio García López, Juan Ignacio Arcelus Martínez. Recurrence of liver metastases from colorectal cancer and repeat liver resectionRevista Española de Enfermedades Digestivas 2015; 107 doi: 10.17235/reed.2015.3843/2015
3
Caroline Theresa Seebauer, Stefan Brunner, Gabriel Glockzin, Pompiliu Piso, Petra Ruemmele, Hans-Juergen Schlitt, Edward Kenneth Geissler, Stefan Fichtner-Feigl, Rebecca Kesselring. Peritoneal carcinomatosis of colorectal cancer is characterized by structural and functional reorganization of the tumor microenvironment inducing senescence and proliferation arrest in cancer cellsOncoImmunology 2016; 5(12): e1242543 doi: 10.1080/2162402X.2016.1242543
4
Ju Seok Kim, Go Eun Bae, Seok-Hwan Kim, Min Kyung Choi, Min-Kyung Yeo. Serum-Based KRASG12/G13 Mutation Detection Using Droplet Digital PCR: Clinical Implications and Limitations in Colorectal Adenocarcinoma With Tumor HeterogeneityFrontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.604772
5
Chun-Hui Cui, Shu-Xin Huang, Jia Qi, Hui-Juan Zhu, Zong-Hai Huang, Jin-Long Yu. Neoadjuvant chemotherapy (NCT) plus targeted agents versus NCT alone in colorectal liver metastases patients: A systematic review and meta-analysisOncotarget 2015; 6(41): 44005 doi: 10.18632/oncotarget.5875
6
TOMOFUMI AKASAKA, MASAHIKO TSUJII, JUMPEI KONDO, YOSHITO HAYASHI, JIN YING, YUQUAN LU, MOTOHIKO KATO, TAKUYA YAMADA, SHUNSUKE YAMAMOTO, TAKUYA INOUE, YOSHIKI TSUJII, AKIRA MAEKAWA, TETSUJI FUJINAGA, ERI SHIRAISHI, SATOSHI HIYAMA, TAKAHIRO INOUE, SHINICHIRO SHINZAKI, KENJI WATABE, TSUTOMU NISHIDA, HIDEKI IIJIMA, TETSUO TAKEHARA. 5-FU resistance abrogates the amplified cytotoxic effects induced by inhibiting checkpoint kinase 1 in p53-mutated colon cancer cellsInternational Journal of Oncology 2015; 46(1): 63 doi: 10.3892/ijo.2014.2693
7
Kyung Ha Lee, Tae Hee Lee, Min Kyung Choi, In Sun Kwon, Go Eun Bae, Min-Kyung Yeo. Identification of a Clinical Cutoff Value for Multiplex KRASG12/G13 Mutation Detection in Colorectal Adenocarcinoma Patients Using Digital Droplet PCR, and Comparison with Sanger Sequencing and PNA Clamping AssayJournal of Clinical Medicine 2020; 9(7): 2283 doi: 10.3390/jcm9072283
8
Benedikt Judmann, Diana Braun, Ralf Schirrmacher, Björn Wängler, Gert Fricker, Carmen Wängler. Toward the Development of GE11-Based Radioligands for Imaging of Epidermal Growth Factor Receptor-Positive TumorsACS Omega 2022; 7(31): 27690 doi: 10.1021/acsomega.2c03407
9
QIU-XIANG WU, SHUANG-XUE YUAN, CHUN-MEI REN, YU YU, WEN-JUAN SUN, BAI-CHENG HE, KE WU. Oridonin upregulates PTEN through activating p38 MAPK and inhibits proliferation in human colon cancer cellsOncology Reports 2016; 35(6): 3341 doi: 10.3892/or.2016.4735
10
Xiaoying Qin, Honghong Luo, Yixuan Deng, Xintong Yao, Jie Zhang, Baicheng He. Resveratrol inhibits proliferation and induces apoptosis via the Hippo/YAP pathway in human colon cancer cellsBiochemical and Biophysical Research Communications 2022; 636: 197 doi: 10.1016/j.bbrc.2022.10.077
11
Diana Braun, Benedikt Judmann, Xia Cheng, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler. Synthesis, Radiolabeling, and In Vitro and In Vivo Characterization of Heterobivalent Peptidic Agents for Bispecific EGFR and Integrin αvβ3 TargetingACS Omega 2023; 8(2): 2793 doi: 10.1021/acsomega.2c07484
12
Alice Bartolini, Sabrina Cardaci, Simona Lamba, Daniele Oddo, Caterina Marchiò, Paola Cassoni, Carla Azzurra Amoreo, Giorgio Corti, Alessandro Testori, Federico Bussolino, Renata Pasqualini, Wadih Arap, Davide Corà, Federica Di Nicolantonio, Serena Marchiò. BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS-Mutant Colorectal CancerClinical Cancer Research 2016; 22(19): 4923 doi: 10.1158/1078-0432.CCR-15-2664
13
Claudia Cardone, Giulia Martini, Teresa Troiani, Stefania Napolitano, Francesco Selvaggi, Fortunato Ciardiello, Erika Martinelli. Genetic Landscape of Primary Versus Metastatic Colorectal Cancer: to What Extent Are They Concordant?Current Colorectal Cancer Reports 2015; 11(5): 217 doi: 10.1007/s11888-015-0278-1
14
Amna Mohamed Taha, Mohammad Mabrouk Aboulwafa, Hamdallah Zedan, Omneya Mohamed Helmy. Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cellsScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-21582-w
15
Deyao Zhao, Yingyi Mo, Margarita E. Neganova, Yulia Aleksandrova, Edmund Tse, Vladimir N. Chubarev, Ruitai Fan, Olga A. Sukocheva, Junqi Liu. Dual effects of radiotherapy on tumor microenvironment and its contribution towards the development of resistance to immunotherapy in gastrointestinal and thoracic cancersFrontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1266537
16
Helen Damerow, Xia Cheng, Valeska von Kiedrowski, Ralf Schirrmacher, Björn Wängler, Gert Fricker, Carmen Wängler. Toward Optimized 89Zr-Immuno-PET: Side-by-Side Comparison of [89Zr]Zr-DFO-, [89Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [89Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?Pharmaceutics 2022; 14(10): 2114 doi: 10.3390/pharmaceutics14102114
17
Kushtrim Kryeziu, Jarle Bruun, Tormod K. Guren, Anita Sveen, Ragnhild A. Lothe. Combination therapies with HSP90 inhibitors against colorectal cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2019; 1871(2): 240 doi: 10.1016/j.bbcan.2019.01.002
18
Benedikt Judmann, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler. Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11Pharmaceuticals 2023; 16(2): 273 doi: 10.3390/ph16020273
19
E Sanchez-Lopez, E Flashner-Abramson, S Shalapour, Z Zhong, K Taniguchi, A Levitzki, M Karin. Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signalingOncogene 2016; 35(20): 2634 doi: 10.1038/onc.2015.326
20
C. Hubert, C. Dahrenmoller, L. Marique, N. Jabbour, P. Gianello, I. Leclercq. Hepatic regeneration in a rat model is impaired by chemotherapy agents used in metastatic colorectal cancerEuropean Journal of Surgical Oncology (EJSO) 2015; 41(11): 1471 doi: 10.1016/j.ejso.2015.08.152
21
Apurva Bonde, Daniel A. Smith, Elias Kikano, Jennifer M. Yoest, Sree H. Tirumani, Nikhil H. Ramaiya. Overview of serum and tissue markers in colorectal cancer: a primer for radiologistsAbdominal Radiology 2021; 46(12): 5521 doi: 10.1007/s00261-021-03243-0
22
SHUANG-XUE YUAN, DONG-XU WANG, QIU-XIANG WU, CHUN-MEI REN, YANG LI, QIAN-ZHAO CHEN, YU-HUA ZENG, YING SHAO, JUN-QIN YANG, YAN BAI, PU ZHANG, YU YU, KE WU, WEN-JUAN SUN, BAI-CHENG HE. BMP9/p38 MAPK is essential for the antiproliferative effect of resveratrol on human colon cancerOncology Reports 2016; 35(2): 939 doi: 10.3892/or.2015.4407
23
Mohammad‐Javad Sanaei, Ayda Baghery Saghchy Khorasani, Atieh Pourbagheri‐Sigaroodi, Shabnam Shahrokh, Mohammad Reza Zali, Davood Bashash. The PI3K/Akt/mTOR axis in colorectal cancer: Oncogenic alterations, non‐coding RNAs, therapeutic opportunities, and the emerging role of nanoparticlesJournal of Cellular Physiology 2022; 237(3): 1720 doi: 10.1002/jcp.30655
24
Neda Amini, Nikolaos Andreatos, Georgios Antonios Margonis, Stefan Buettner, Jaeyun Wang, Boris Galjart, Doris Wagner, Kazunari Sasaki, Anastasios Angelou, Jinger Sun, Carsten Kamphues, Andrea Beer, Daisuke Morioka, Inger Marie Løes, Efstathios Antoniou, Katsunori Imai, Emmanouil Pikoulis, Jin He, Klaus Kaczirek, George Poultsides, Cornelis Verhoef, Per Eystein Lønning, Itaru Endo, Hideo Baba, Peter Kornprat, Federico NAucejo, Martin E. Kreis, Wolfgang L. Christopher, Matthew J. Weiss, Bashar Safar, Richard Andrew Burkhart. Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?Journal of Hepato-Biliary-Pancreatic Sciences 2022; 29(4): 417 doi: 10.1002/jhbp.1054
25
Nanako Hata, Kunitoshi Shigeyasu, Yuzo Umeda, Shuya Yano, Sho Takeda, Kazuhiro Yoshida, Tomokazu Fuji, Ryuichi Yoshida, Kazuya Yasui, Hibiki Umeda, Toshiaki Takahashi, Yoshitaka Kondo, Hiroyuki Kishimoto, Yoshiko Mori, Fuminori Teraishi, Hideki Yamamoto, Hiroyuki Michiue, Keiichiro Nakamura, Hiroshi Tazawa, Toshiyoshi Fujiwara. ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancerScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-29397-z
26
Magdalena Szaryńska, Agata Olejniczak, Jarosław Kobiela, Piotr Spychalski, Zbigniew Kmieć. Therapeutic strategies against cancer stem cells in human colorectal cancer (Review)Oncology Letters 2017;  doi: 10.3892/ol.2017.7261
27
María González-González, María Laura Gutiérrez, José María Sayagués, Luis Muñoz-Bellvís, Alberto Orfao. Genomic profiling of sporadic liver metastatic colorectal cancerSeminars in Cancer Biology 2021; 71: 98 doi: 10.1016/j.semcancer.2020.05.013
28
Yawen Dong, Jonas Santol, Birgit Gruenberger, Alfred Lenauer, Friedrich Laengle, Josef Thaler, Gudrun Piringer, Wolfgang Eisterer, Angela Djanani, Judith Stift, Thomas Gruenberger. Perioperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer: Long-Term Follow-Up of the ASSO-LM1 TrialCancers 2024; 16(5): 857 doi: 10.3390/cancers16050857
29
In Seon Lee, Seung Joon Choi, Cho Rong Seo, Jun Seong Kim. Comparison of the Response Evaluation Criteria in Solid Tumors with Volumetric Measurement for Evaluation of Response and Overall Survival with Liver Metastases from Colorectal CancerJournal of the Korean Society of Radiology 2019; 80(5): 906 doi: 10.3348/jksr.2019.80.5.906
30
Alessandra Tessitore, Gemma Bruera, Valentina Mastroiaco, Katia Cannita, Alessio Cortellini, Valentina Cocciolone, Antonella Dal Mas, Giuseppe Calvisi, Francesca Zazzeroni, Corrado Ficorella, Enrico Ricevuto, Edoardo Alesse. KRAS and 2 rare PI3KCA mutations coexisting in a metastatic colorectal cancer patient with aggressive and resistant diseaseHuman Pathology 2018; 74: 178 doi: 10.1016/j.humpath.2018.01.021